Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finlay

Showing results (371-380 of 394) with videos related to

Pageof 40
Sort By:
Journal of Medicinal Chemistry|March 14, 2012
Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a potent and selective I(Kur) inhibitorHeather J Finlay, John Lloyd, Wayne Vaccaro, et al.
Journal of Molecular Biology|February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potentialCiara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2015
Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodiesSue Townsend, Brian J Fennell, James R Apgar, et al.
Gastroenterology|October 13, 2006
Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumorsJens K Habermann, Uwe J Roblick, Brian T Luke, et al.
Journal of Molecular Biology|March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regionsWilliam J Finlay, Orla Cunningham, Matthew A Lambert, et al.
Frontiers in Oncology|January 24, 2014
Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased SurvivalStacey Ann N D'mello, Jack U Flanagan, Taryn N Green, et al.
Journal of Medicinal Chemistry|March 10, 2021
Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical CandidateJames A Johnson, Soong-Hoon Kim, Ji Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2018
Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitorsCarol H Hu, Tammy C Wang, Jennifer X Qiao, et al.
Mabs|December 23, 2017
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokineticsLindsay B Avery, Jason Wade, Mengmeng Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2014
Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitorsYufeng Wang, Wu Yang, Heather J Finlay, et al.
Pageof 40

Showing results (371-380 of 394) with videos related to

Sort By:
Pageof 40
Journal of Medicinal Chemistry|March 14, 2012
Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a potent and selective I(Kur) inhibitorHeather J Finlay, John Lloyd, Wayne Vaccaro, et al.
Journal of Molecular Biology|February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potentialCiara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2015
Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodiesSue Townsend, Brian J Fennell, James R Apgar, et al.
Gastroenterology|October 13, 2006
Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumorsJens K Habermann, Uwe J Roblick, Brian T Luke, et al.
Journal of Molecular Biology|March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regionsWilliam J Finlay, Orla Cunningham, Matthew A Lambert, et al.
Frontiers in Oncology|January 24, 2014
Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased SurvivalStacey Ann N D'mello, Jack U Flanagan, Taryn N Green, et al.
Journal of Medicinal Chemistry|March 10, 2021
Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical CandidateJames A Johnson, Soong-Hoon Kim, Ji Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2018
Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitorsCarol H Hu, Tammy C Wang, Jennifer X Qiao, et al.
Mabs|December 23, 2017
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokineticsLindsay B Avery, Jason Wade, Mengmeng Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2014
Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitorsYufeng Wang, Wu Yang, Heather J Finlay, et al.
Pageof 40